Ensign Peak Advisors
KRSA

Ensign Peak Advisors’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

Ensign Peak Advisors’s Portfolio KRSA Stock Details KRSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-494
Closed -$420K – 1863
2020
Q3 		$420K Buy
494
+302
+157% +$34.5K ﹤0.01% 1571
2020
Q2 		$159K Hold
192
– – ﹤0.01% 1602
2020
Q1 		$71K Buy
+192
New +$13.7K ﹤0.01% 1588

Other funds holding KRSA

SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ensign Peak Advisors's KRSA Position: Q4 2020 in Review

Ensign Peak Advisors sold out of Korsana Biosciences, Inc. Common Stock (KRSA) in Q4 2020, closing a stake of 494 shares — an estimated $420K sold.

Ensign Peak Advisors first reported a position in KRSA in Q1 2020 and held it in 3 quarters. The position peaked at $420K in Q3 2020. 70 funds tracked by Wall St. Rank hold KRSA as of Q4 2020.

  • Ensign Peak Advisors reported no remaining Korsana Biosciences, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Ensign Peak Advisors sold 494 Korsana Biosciences, Inc. Common Stock shares in Q4 2020, an estimated $420K.
  • Ensign Peak Advisors first reported a position in Korsana Biosciences, Inc. Common Stock in Q1 2020 and held it in 3 quarters.
  • Ensign Peak Advisors's Korsana Biosciences, Inc. Common Stock position peaked at $420K in Q3 2020.
  • 70 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q4 2020.

Based on Ensign Peak Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.